2 hours agoPolitics
34LENS
7 SourcesUnited States
thebalanced.newsTrump Signs Executive Order to Accelerate Research on Psychedelic Drugs Including Ibogaine
President Donald Trump signed an executive order directing the FDA to expedite research and review of psychedelic drugs, including ibogaine, to explore their potential in treating conditions like PTSD and traumatic brain injuries, especially among military veterans. The order aims to remove regulatory barriers, provide clearer clinical trial guidance, and includes a $50 million federal investment to support state-level research. While ibogaine remains a Schedule I substance in the US, proponents highlight its therapeutic promise despite safety concerns. The announcement received bipartisan support and featured advocates like podcaster Joe Rogan.
Political Bias
17%74%9%
Sentiment
68%
AI Analysis
Political bias across 7 sources
● Left 17%● Center 74%● Right 9%
The article group presents perspectives from the Trump administration emphasizing veteran health benefits and regulatory reform, alongside advocacy voices such as Joe Rogan. Coverage includes bipartisan support references and acknowledges safety concerns, reflecting a range of viewpoints from government officials, veterans' groups, and psychedelic therapy proponents without favoring any political ideology.
Sentiment — Positive (68/100)
The overall tone across the articles is cautiously optimistic, highlighting potential medical benefits of psychedelics for mental health while noting existing safety and legal challenges. Statements from Trump and supporters convey hope for improved treatments, balanced by acknowledgment of regulatory hurdles and risks, resulting in a generally positive but measured sentiment.
How 4 sources covered this story
Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.
| Source | Their headline | Bias | Sentiment |
|---|---|---|---|
| hindustantimes | Trump vs Joe Rogan reaches the White House; quips 'I'd like some Ibogaine' after signing new order | Center | Neutral |
| hindustantimes | What is ibogaine? Trump signs order to fast track psychedelic drug research, here's why | Center | Positive |
| wion | Trump signs executive order to fast-track psychedelic drug research, announces 50 million support | Center | Positive |
| moneycontrol | Trump signs order easing restrictions on psychedelic drugs- Moneycontrol.com | Center | Positive |
Coverage timeline
moneycontrol broke this story on 18 Apr, 02:17 pm. Other outlets followed.
- 1moneycontrol18 Apr, 02:17 pmTrump signs order easing restrictions on psychedelic drugs- Moneycontrol.com
- 2wion18 Apr, 02:40 pmTrump signs executive order to fast-track psychedelic drug research, announces 50 million support
- 3hindustantimes18 Apr, 02:58 pmWhat is ibogaine? Trump signs order to fast track psychedelic drug research, here's why
- 4hindustantimes18 Apr, 03:14 pmTrump vs Joe Rogan reaches the White House; quips 'I'd like some Ibogaine' after signing new order
Lens Score breakdown
34/100
Public interest0/100
Coverage gap90%
Well-covered story — coverage matches public importance.
Who's involved
Institutions and figures named across source coverage.
Government
Department of Veterans AffairsUS Federal GovernmentFood and Drug AdministrationWhite HouseHealth and Human ServicesUS Food and Drug Administration
Political
President Donald TrumpBiden AdministrationFederal Health OfficialsDonald TrumpUS President
Story context
- Category
- Politics
- Location
- United States
- Sources analysed
- 7
- Last analysed
- 18 Apr 2026
- Key entities
- Post-traumatic stress disorderDonald TrumpFood and Drug AdministrationIbogainePsychedelic drugClinical trialMental disorderUnited StatesExecutive order (United States)PsilocybinPodcastLSD
Related Coverage
Select a news story to see related coverage from other media outlets.